PD‐L1 promotes OCT4 and Nanog expression in breast cancer stem cells by sustaining PI3K/AKT pathway activation

The expression of PD‐L1 in breast cancer is associated with estrogen receptor negativity, chemoresistance and epithelial‐to‐mesenchymal transition (EMT), all of which are common features of a highly tumorigenic subpopulation of cancer cells termed cancer stem cells (CSCs). Hitherto, the expression a...

Descripción completa

Detalles Bibliográficos
Autores principales: Almozyan, Sheema, Colak, Dilek, Mansour, Fatmah, Alaiya, Ayodele, Al‐Harazi, Olfat, Qattan, Amal, Al‐Mohanna, Falah, Al‐Alwan, Monther, Ghebeh, Hazem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Molecular Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575465/
https://www.ncbi.nlm.nih.gov/pubmed/28614911
http://dx.doi.org/10.1002/ijc.30834

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575465/
https://www.ncbi.nlm.nih.gov/pubmed/28614911
http://dx.doi.org/10.1002/ijc.30834

Ejemplares similares